Canadian variation [NCA / SHAM]

posted by Parveen Arora – 2012-05-22 10:35 (5137 d 02:37 ago) – Posting: # 8597
Views: 8,312

Dear All,

For ODT formulations [like- triptans for migraine treatment], kindly clarify, whether AUCReftmax is to be calculated and presented or to be include in BE acceptance criteria?

Regards
Parveen Arora

Complete thread:

UA Flag
Activity
 Admin contact
23,654 posts in 4,992 threads, 1,570 registered users;
118 visitors (0 registered, 118 guests [including 14 identified bots]).
Forum time: 13:12 CEST (Europe/Vienna)

The idea is to try and give all the information to help others
to judge the value of your contribution;
not just the information that leads to judgment
in one particular direction or another.    Richard Feynman

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5